MedTrace Logo

Specified Drug Use-results Survey of Betanis Tablets

NCT01898624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2018-02-05

No results posted yet for this study

Summary

To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.

Conditions

Interventions

DRUG

mirabegron

oral

Sponsors & Collaborators

  • Astellas Pharma Inc

    lead INDUSTRY

Principal Investigators

  • Central Contact · Astellas Pharma Inc

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-04
Primary Completion
2018-01-10
Completion
2018-01-10

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01898624 on ClinicalTrials.gov